John D. Minna
Impact in
- Oncology top 0.01%
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
- Cancer Research top 0.01%
- Cancer Genomics and Diagnostics
Papers in
-
- RNA modifications and cancer 119
- Epigenetics and DNA Methylation 76
- Oncology 292
- Lung Cancer Research Studies 135
- Cancer-related Molecular Pathways 61
- Peptidase Inhibition and Analysis 42
- Co-authors
- Adi F. Gazdar (222 shared papers)Paul A. Bunn (76 shared papers)Luc Girard (135 shared papers)William DeGraff (3 shared papers)James Carmichael (3 shared papers)Desmond N. Carney (27 shared papers)Ignacio I. Wistuba (98 shared papers)Robert C. Gallo (3 shared papers)
- Journals
- Cancer Research (79 papers)Oncogene (39 papers)Proceedings of the National Academy of Sciences (29 papers)Clinical Cancer Research (28 papers)Journal of Thoracic Oncology (24 papers)
- Partner nations
- United StatesJapanChina
In The Last Decade
John D. Minna
786 papers receiving 71.1k citations
John D. Minna's Hit Papers
Peers
Comparison fields: 5 of 201
- Oncology 23.3k
- Cancer Research 11.3k
- Molecular Biology 37.6k
- Pulmonary and Respiratory Medicine 12.4k
- Immunology 8.3k
Countries citing papers authored by John D. Minna
This map shows the geographic impact of John D. Minna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Minna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Minna more than expected).
Fields of papers citing papers by John D. Minna
This network shows the impact of papers produced by John D. Minna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Minna. The network helps show where John D. Minna may publish in the future.
Co-authors
The 25 scholars most cited alongside John D. Minna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 801 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma Hit paper breakdown → | 1980 | 4125 |
| 2 | Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Hit paper breakdown → | 1987 | 3546 |
| 3 | Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer Hit paper breakdown → | 1985 | 1163 |
| 4 | p53: A Frequent Target for Genetic Abnormalities in Lung Cancer Hit paper breakdown → | 1989 | 1054 |
| 5 | BRAF and RAS mutations in human lung cancer and melanoma. Hit paper breakdown → | 2002 | 843 |
| 6 | Amplification and expression of the c-myc oncogene in human lung cancer cell lines Hit paper breakdown → | 1983 | 778 |
| 7 | Abnormalities in Structure and Expression of the Human Retinoblastoma Gene in SCLC Hit paper breakdown → | 1988 | 754 |
| 8 | Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data Hit paper breakdown → | 2019 | 738 |
| 9 | Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Hit paper breakdown → | 1987 | 630 |
| 10 | Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery Hit paper breakdown → | 2009 | 615 |
| 11 | Small-cell lung cancer: what we know, what we need to know and the path forward Hit paper breakdown → | 2017 | 593 |
| 12 | NRF2 regulates serine biosynthesis in non–small cell lung cancer Hit paper breakdown → | 2015 | 575 |
| 13 | L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer Hit paper breakdown → | 1985 | 546 |
| 14 | Somatic Mutations of the HER2 Kinase Domain in Lung Adenocarcinomas Hit paper breakdown → | 2005 | 518 |
| 15 | Differential expression of myc family genes during murine development Hit paper breakdown → | 1986 | 483 |
| 16 | 2007 | 473 | |
| 17 | The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. | 2000 | 464 |
| 18 | 1990 | 441 | |
| 19 | EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance Hit paper breakdown → | 2013 | 429 |
| 20 | 2002 | 428 |
About John D. Minna
John D. Minna is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Epidemiology, having authored 801 papers that have together received 73.5k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (135 papers), Lung Cancer Treatments and Mutations (134 papers), RNA modifications and cancer (119 papers), Epigenetics and DNA Methylation (76 papers), Cancer-related Molecular Pathways (61 papers), Neuroendocrine Tumor Research Advances (61 papers), Cancer Genomics and Diagnostics (58 papers) and Peptidase Inhibition and Analysis (42 papers). The work is most often cited by research in Oncology (23.3k citations), Cancer Research (11.3k citations), Molecular Biology (37.6k citations), Pulmonary and Respiratory Medicine (12.4k citations) and Immunology (8.3k citations). John D. Minna has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Adi F. Gazdar, Paul A. Bunn, Luc Girard, William DeGraff, James Carmichael, Desmond N. Carney, Ignacio I. Wistuba, Robert C. Gallo, Bernard J. Poiesz and James B. Mitchell. Their work appears in journals such as Cancer Research, Oncogene, Proceedings of the National Academy of Sciences, Clinical Cancer Research and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.